Dr. Parkman has been actively involved in studying GI motility at Temple University School of Medicine at the basic science and clinical levels. His clinical focus has been treating patients with GI motility disorders. Clinically, Dr. Parkman oversees the GI Motility Laboratory. His clinical laboratory has developed expertise in a comprehensive array of GI motility tests for clinical evaluation of patients. Dr. Parkman was funded for 10 years with an NIH K24 Midcareer Investigator Award in Patient-Oriented Research where he mentored young investigators in clinical research. Dr. Parkman is currently a funded member of the NIH Gastroparesis Clinical Research Consortium. During his presidency of the American Neurogastroenterological and Motility Society, Dr. Parkman helped standardize the radionuclide gastric emptying study resulting in a standardized test. He remains active with an initiative to develop a patient-reported outcome (PRO) for gastroparesis that meets the approval of the Food and Drug Administration (FDA).

• SECTION 1 Overview of Upper Digestive TractSECTION 2 Mouth and PharynxSECTION 3 EsophagusSECTION 4 Stomach

Dr. Parkman has been actively involved in studying GI motility at Temple University School of Medicine at the basic science and clinical levels. His clinical focus has been treating patients with GI motility disorders. Clinically, Dr. Parkman oversees the GI Motility Laboratory. His clinical laboratory has developed expertise in a comprehensive array of GI motility tests for clinical evaluation of patients. Dr. Parkman was funded for 10 years with an NIH K24 Midcareer Investigator Award in Patient-Oriented Research where he mentored young investigators in clinical research. Dr. Parkman is currently a funded member of the NIH Gastroparesis Clinical Research Consortium. During his presidency of the American Neurogastroenterological and Motility Society, Dr. Parkman helped standardize the radionuclide gastric emptying study resulting in a standardized test. He remains active with an initiative to develop a patient-reported outcome (PRO) for gastroparesis that meets the approval of the Food and Drug Administration (FDA).

• SECTION 1 Overview of Upper Digestive TractSECTION 2 Mouth and PharynxSECTION 3 EsophagusSECTION 4 Stomach

Dr. Parkman has been actively involved in studying GI motility at Temple University School of Medicine at the basic science and clinical levels. His clinical focus has been treating patients with GI motility disorders. Clinically, Dr. Parkman oversees the GI Motility Laboratory. His clinical laboratory has developed expertise in a comprehensive array of GI motility tests for clinical evaluation of patients. Dr. Parkman was funded for 10 years with an NIH K24 Midcareer Investigator Award in Patient-Oriented Research where he mentored young investigators in clinical research. Dr. Parkman is currently a funded member of the NIH Gastroparesis Clinical Research Consortium. During his presidency of the American Neurogastroenterological and Motility Society, Dr. Parkman helped standardize the radionuclide gastric emptying study resulting in a standardized test. He remains active with an initiative to develop a patient-reported outcome (PRO) for gastroparesis that meets the approval of the Food and Drug Administration (FDA).

• SECTION 1 Overview of Upper Digestive TractSECTION 2 Mouth and PharynxSECTION 3 EsophagusSECTION 4 Stomach